Concepedia

Walter W. Offen

WW

Statistics

Publications

2

Citations

71

H-Index

2

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Walter W. Offen is an author at Eli Lilly (United States) specializing in molecular pharmacology, drug discovery, and neuroimmunology.

Top concepts

Publications per year

1998–1999

2

Publications

2

Efficacy of Xanomeline in Alzheimer Disease: Cognitive Improvement Measured Using the Computerized Neuropsychological Test Battery (CNTB)

Amy E. Veroff, N. Bodick, Walter W. Offen et al. · Alzheimer Disease & Associated Disorders · 1998 · 60 citations

Lanepitant, an NK-1 antagonist, in migraine prophylaxis

D. S. Goldstein, Walter W. Offen, Eric A. Klein · Clinical Pharmacology & Therapeutics · 1999 · 11 citations

, , +14

1–2 of 2